当前位置：首页 SCI 期刊医学 Journal Of Thrombosis And Thrombolysis(非官网)

Journal Of Thrombosis And ThrombolysisSCIE

国际简称：J THROMB THROMBOLYS 参考译名：血栓形成和溶栓杂志

中科院分区
3区
CiteScore分区
Q1
JCR分区
Q2

基本信息：: ISSN：0929-5305; E-ISSN：1573-742X; 是否OA：未开放; 是否预警：否; TOP期刊：否

出版信息：: 出版地区：NETHERLANDS; 出版商：Springer US; 出版语言：English; 出版周期：Bimonthly; 出版年份：1994; 研究方向：医学-外周血管病

评价信息：: 影响因子：2.3; H-index：59; CiteScore指数：9.2; SJR指数：0.744; SNIP指数：0.801

发文数据：: Gold OA文章占比：24.71%; 研究类文章占比：90.60%; 年发文量：149; 自引率：0; 开源占比：0.1446; 出版撤稿占比：0; 出版国人文章占比：0.09; OA被引用占比：0.1100...

投稿咨询加急见刊

英文简介期刊介绍 CiteScore数据中科院SCI分区 JCR分区发文数据常见问题

英文简介Journal Of Thrombosis And Thrombolysis期刊介绍

The Journal of Thrombosis and Thrombolysis is a long-awaited resource for contemporary cardiologists, hematologists, vascular medicine specialists and clinician-scientists actively involved in treatment decisions and clinical investigation of thrombotic disorders involving the cardiovascular and cerebrovascular systems. The principal focus of the Journal centers on the pathobiology of thrombosis and vascular disorders and the use of anticoagulants, platelet antagonists, cell-based therapies and interventions in scientific investigation, clinical-translational research and patient care.

The Journal will publish original work which emphasizes the interface between fundamental scientific principles and clinical investigation, stimulating an interdisciplinary and scholarly dialogue in thrombosis and vascular science. Published works will also define platforms for translational research, drug development, clinical trials and patient-directed applications. The Journal of Thrombosis and Thrombolysis' integrated format will expand the reader's knowledge base and provide important insights for both the investigation and direct clinical application of the most rapidly growing fields in medicine-thrombosis and vascular science.

期刊简介Journal Of Thrombosis And Thrombolysis期刊介绍

《Journal Of Thrombosis And Thrombolysis》自1994出版以来，是一本医学优秀杂志。致力于发表原创科学研究结果，并为医学各个领域的原创研究提供一个展示平台，以促进医学领域的的进步。该刊鼓励先进的、清晰的阐述，从广泛的视角提供当前感兴趣的研究主题的新见解，或审查多年来某个重要领域的所有重要发展。该期刊特色在于及时报道医学领域的最新进展和新发现新突破等。该刊近一年未被列入预警期刊名单，目前已被权威数据库SCIE收录，得到了广泛的认可。

该期刊投稿重要关注点：

预计审稿时间：偏慢,4-8周
医学
HEMATOLOGY
SCIE
中科院3区
非预警

Cite Score数据（2024年最新版）Journal Of Thrombosis And Thrombolysis Cite Score数据

CiteScore：9.2
SJR：0.744
SNIP：0.801

学科类别	分区	排名	百分位
大类：Medicine 小类：Cardiology and Cardiovascular Medicine	Q1	53 / 387	86%
大类：Medicine 小类：Hematology	Q1	22 / 137	84%

CiteScore 是由Elsevier(爱思唯尔)推出的另一种评价期刊影响力的文献计量指标。反映出一家期刊近期发表论文的年篇均引用次数。CiteScore以Scopus数据库中收集的引文为基础，针对的是前四年发表的论文的引文。CiteScore的意义在于，它可以为学术界提供一种新的、更全面、更客观地评价期刊影响力的方法，而不仅仅是通过影响因子(IF)这一单一指标来评价。

历年Cite Score趋势图

中科院SCI分区Journal Of Thrombosis And Thrombolysis 中科院分区

中科院 2023年12月升级版 综述期刊：否 Top期刊：否

大类学科	分区	小类学科	分区
医学	3区	HEMATOLOGY 血液学 CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 PERIPHERAL VASCULAR DISEASE 外周血管病	3区 4区 4区

中科院分区表 是以客观数据为基础，运用科学计量学方法对国际、国内学术期刊依据影响力进行等级划分的期刊评价标准。它为我国科研、教育机构的管理人员、科研工作者提供了一份评价国际学术期刊影响力的参考数据，得到了全国各地高校、科研机构的广泛认可。

中科院分区表 将所有期刊按照一定指标划分为1区、2区、3区、4区四个层次，类似于“优、良、及格”等。最开始，这个分区只是为了方便图书管理及图书情报领域的研究和期刊评估。之后中科院分区逐步发展成为了一种评价学术期刊质量的重要工具。

历年中科院分区趋势图

JCR分区Journal Of Thrombosis And Thrombolysis JCR分区

2023-2024 年最新版

按JIF指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	103 / 220	53.4%
学科：HEMATOLOGY	SCIE	Q2	48 / 97	51%
学科：PERIPHERAL VASCULAR DISEASE	SCIE	Q2	44 / 96	54.7%

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：CARDIAC & CARDIOVASCULAR SYSTEMS	SCIE	Q2	67 / 220	69.77%
学科：HEMATOLOGY	SCIE	Q2	29 / 97	70.62%
学科：PERIPHERAL VASCULAR DISEASE	SCIE	Q1	24 / 96	75.52%

JCR分区的优势在于它可以帮助读者对学术文献质量进行评估。不同学科的文章引用量可能存在较大的差异，此时单独依靠影响因子(IF)评价期刊的质量可能是存在一定问题的。因此，JCR将期刊按照学科门类和影响因子分为不同的分区，这样读者可以根据自己的研究领域和需求选择合适的期刊。

历年影响因子趋势图

发文数据

2023-2024 年国家/地区发文量统计

国家/地区数量
USA364
Italy98
CHINA MAINLAND97
GERMANY (FED REP GER)50
Japan44
England38
Canada36
France28
Australia24
Israel21

本刊中国学者近年发表论文

1、Safety and efficacy of fibrinogen concentrate in aortic arch surgery involving moderate hypothermic circulatory arrest
Author: Guan, Xinliang; Li, Lei; Lu, Xuran; Gong, Ming; Li, Haiyang; Liu, Yuyong; Jiang, Wenjian; Lan, Feng; Wang, Xiaolong; Zhang, Hongjia

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 1, pp. 67-73. DOI: 10.1007/s11239-022-02706-5
2、Delayed neurological improvement after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry
Author: Sun, Dapeng; Raynald; Huo, Xiaochuan; Jia, Baixue; Tong, Xu; Ma, Gaoting; Wang, Anxin; Ma, Ning; Gao, Feng; Mo, Dapeng; Miao, Zhongrong

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 1, pp. 1-8. DOI: 10.1007/s11239-022-02712-7
3、Empagliflozin activates JAK2/STAT3 signaling and protects cardiomyocytes from hypoxia/reoxygenation injury under high glucose conditions
Author: Zhang, Fan; Cao, Xudong; Zhao, Chunhui; Chen, Li; Chen, Xiaolin

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 1, pp. 116-125. DOI: 10.1007/s11239-022-02719-0
4、Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis
Author: Zheng, Xiaojie; Gao, Fangbo; Wang, Le; Meng, Yao; Ageno, Walter; Qi, Xingshun

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 1, pp. 18-31. DOI: 10.1007/s11239-022-02732-3
5、Role of cerebral microbleeds in acute ischemic stroke and atrial fibrillation
Author: Wang, Meng; Yang, Yuyuan; Luan, Moxin; Wang, Yajuan; Zhong, Meixiang; Xu, Lulu; Zheng, Xueping

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 3, pp. 553-565. DOI: 10.1007/s11239-022-02761-y
6、Causal relationship between moderate to vigorous physical activity and venous thromboembolism
Author: Hu, Mengjin; Wang, Xiaoning; Yang, Yuejin

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 3, pp. 576-583. DOI: 10.1007/s11239-022-02754-x
7、Age at smoking initiation and smoking cessation influence the incidence of stroke in China: a 10-year follow-up study
Author: Liang, Tian; Xie, Changping; Lv, Bangjun; Su, Li; Long, Jianxiong; Liu, Shengying; Huang, Xiaolan; Pei, Pei; Pan, Rong; Lan, Jian

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. , Issue , pp. -. DOI: 10.1007/s11239-023-02812-y
8、Angiojet pharmacomechanical thrombectomy versus anticoagulant therapy alone in massive cancer-associated thrombosis: a single centre retrospective cohort study
Author: Gong, Maofeng; Fu, Guanqi; Liu, Zhengli; Zhao, Boxiang; Kong, Jie; He, Xu; Gu, Jianping

Journal: JOURNAL OF THROMBOSIS AND THROMBOLYSIS. 2023; Vol. 55, Issue 2, pp. 365-375. DOI: 10.1007/s11239-023-02770-5